Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

2.

From total empiricism to a rational design of metronomic chemotherapy phase I dosing trials.

Lam T, Hetherington JW, Greenman J, Maraveyas A.

Anticancer Drugs. 2006 Feb;17(2):113-21. Review.

PMID:
16428928
3.

Can a rational design for metronomic chemotherapy dosing be devised?

Maraveyas A, Lam T, Hetherington JW, Greenman J.

Br J Cancer. 2005 Apr 25;92(8):1588-90. No abstract available.

4.

The role of Acucise endopyelotomy in the treatment of ureteropelvic junction obstruction.

Biyani CS, Minhas S, el Cast J, Almond DJ, Cooksey G, Hetherington JW.

Eur Urol. 2002 Mar;41(3):305-10; discussion 310-1.

PMID:
12180233
5.

Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies.

Summerton N, Mann S, Rigby AS, Ashley J, Palmer S, Hetherington JW.

Br J Gen Pract. 2002 Apr;52(477):284-9. Review.

6.
7.

A pilot study of intermittent androgen deprivation in advanced prostate cancer.

Horwich A, Huddart RA, Gadd J, Boyd PJ, Hetherington JW, Whelan P, Dearnaley DP.

Br J Urol. 1998 Jan;81(1):96-9.

PMID:
9467483
8.

Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22.

Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, Bentley E, Affara NA, Ferguson-Smith MA, Maher ER.

Br J Cancer. 1994 Feb;69(2):230-4.

9.

Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit.

Hendry WF, A'Hern RP, Hetherington JW, Peckham MJ, Dearnaley DP, Horwich A.

Br J Urol. 1993 Feb;71(2):208-13.

PMID:
8384914
10.

A double-blind single dose comparison of intramuscular ketorolac tromethamine and pethidine in the treatment of renal colic.

Oosterlinck W, Philp NH, Charig C, Gillies G, Hetherington JW, Lloyd J.

J Clin Pharmacol. 1990 Apr;30(4):336-41.

PMID:
2341581
11.
12.

Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.

Hetherington JW, Newling DW, Robinson MR, Smith PH, Adib RS, Whelan P.

Br J Urol. 1987 Mar;59(3):239-41.

PMID:
3105631
13.

Prevalence of chlamydial infection in acute epididymo-orchitis.

Mulcahy FM, Bignell CJ, Rajakumar R, Waugh MA, Hetherington JW, Ewing R, Whelan P.

Genitourin Med. 1987 Feb;63(1):16-8.

14.

Surgical salvage of advanced testicular tumours.

Ewing R, Hetherington JW, Jones WG, Williams RE.

Br J Urol. 1987 Jan;59(1):76-80.

PMID:
3828691
15.

Urinary fibrin/fibrinogen degradation products in transitional cell carcinoma of the bladder.

Ewing R, Tate GM, Hetherington JW.

Br J Urol. 1987 Jan;59(1):53-8.

PMID:
3828688
16.

Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex).

Siddall JK, Hetherington JW, Cooper EH, Newling DW, Robinson MR, Richards B, Denis L.

Br J Urol. 1986 Dec;58(6):676-82.

PMID:
2432985
17.

Modified nephroureterectomy: a risk of tumour implantation.

Hetherington JW, Ewing R, Philp NH.

Br J Urol. 1986 Aug;58(4):368-70.

PMID:
3756402
18.

Persistent ulcers after bladder instillation of mitomycin C.

Hetherington JW, Whelan P.

Lancet. 1986 Feb 8;1(8476):324. No abstract available.

PMID:
2868188
19.

Diclofenac sodium versus pethidine in acute renal colic.

Hetherington JW, Philp NH.

Br Med J (Clin Res Ed). 1986 Jan 25;292(6515):237-8. No abstract available.

21.

Hydrostatic bladder distension for bladder cancer.

Smith PH, Hetherington JW.

Prog Clin Biol Res. 1984;162B:309-19. No abstract available.

PMID:
6504901
22.

Intravesical chemotherapy--other agents.

Smith PH, Cruickshank J, Hetherington JW.

Prog Clin Biol Res. 1984;162B:173-9. No abstract available.

PMID:
6504895

Supplemental Content

Loading ...
Support Center